Biotechnology is rapidly expanding beyond the lab, enabling a new generation of sustainable materials with the potential to reshape global industries. Turning scientific breakthroughs into scalable businesses, however, requires more than innovation. It demands long-term vision, patient capital, and strong execution. Bridging builder and investor perspectives, this conversation looks at what it takes to commercialize deeptech, finance industrial transformation, and build companies capable of delivering both economic and environmental value.
